My watch list
my.bionity.com  
Login  
NEWS
Current news

Known active ingredient as new drug candidate against “monkeypox”

21-Mar-2023 Mpox – previously known as "monkeypox" – is currently spreading worldwide. An international research team from Goethe University and the University of Kent has now identified a compound that could help fight the disease. Their study has been published in the “Journal of Medical Virology”. N ... more

Successful exit: Miltenyi Biotec acquires biosensor company lino Biotech

21-Mar-2023 lino Biotech, a biosensor company and the world’s only provider of Focal Molography®, announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new ... more

Where the HI-Virus sleeps in the brain

20-Mar-2023 The human immunodeficiency virus HIV-1 is able to infect various tissues in humans. Once inside the cells, the virus integrates its genome into the cellular genome and establishes persistent infections. The role of the structure and organisation of the host genome in HIV-1 infection is not ... more

Survival specialists on Mount Everest

Humans are leaving behind a ‘frozen signature’ of hardy microbes

20-Mar-2023 Almost 5 miles above sea level in the Himalayan mountains, the rocky dip between Mount Everest and its sister peak, Lhotse, lies windswept, free of snow. It is here at the South Col where hundreds of adventurers pitch their final camp each year before attempting to scale the world’s tallest ... more

INTEGRA Biosciences acquires start-up Miroculus to accelerate genomics

20-Mar-2023 INTEGRA Biosciences announced that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant tim ... more

Immune-cell booster for cancer patients

“This would make it possible to administer cells from any donor to any patient” - Spin-off company planned

20-Mar-2023 Cancer patients might one day benefit from being administered immune cells from healthy donors. But as things stand, receiving donor cells can cause severe or even fatal immune reactions. A researcher at ETH Zurich has now developed a technology that avoids these. Edo Kapetanovic is a medic ... more

GSG GENII Software Group acquires iVention

17-Mar-2023 GSG GENII Software Group announces that it has completed the acquisition of iVention. iVention provides laboratories in a wide range of industries with its powerful and flexible iVention Lab Execution System (iLES), a software system designed specifically for and around the laboratory proce ... more

Extinction vulnerability during biodiversity crises is unpredictable

Despite the use of AI

17-Mar-2023 Predicting extinction vulnerability during a modern-day biodiversity crisis is a key objective for scientists. One approach is to use evidence from the past to make forecasts for the future. A team of researchers led by William Foster from Hamburg University used fossils from past mass exti ... more

‘Glow-in-the-dark’ proteins could help diagnose viral diseases

Diagnose diseases more quickly and easily

17-Mar-2023 Despite recent advancements, many highly sensitive diagnostic tests for viral diseases still require complicated techniques to prepare a sample or interpret a result, making them impractical for point-of-care settings or areas with few resources. But now, a team reporting in ACS Central Sci ... more

BluCon Biotech and LG Chem enter into unique investment agreement

BluCon Biotech's technology has the potential to be a disruptive game changer in the world's plastics market

16-Mar-2023 BluCon Biotech, a German biotech company, and LG Chem, a Korean chemical company, have entered into an investment agreement to scale up and commercialize BluCon Biotech’s proprietary technology to supplement LG Chem´s bio-economy portfolio BluCon Biotech’s technology has the potential to be ... more

All news

New organ-on-chip pilot seeks to reduce animal testing in consumer health industry

Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital

08-Mar-2023 A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software. The pilot project, supported by esqLABS, Dynamic42, Placenta Lab of Jena Un ... more

New method for the detection of RNA viruses such as SARS-CoV-2

An effective and faster methodology than the PCR test

01-Mar-2023 Experts from the University of Barcelona, the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), the Institute of Microelectronics of Barcelona (IMB-CNM-CSIC) and the Aragon Nanoscience and Materials Institute of Aragon (INMA) —a joint institute of the CSIC and the University of Zar ... more

Genomics for biodiversity conservation

Genomic analyses provide important insights for conservation management

28-Feb-2023 Conserving nature’s biodiversity is one of the great challenges of our time. To develop strategies and effective measures, well-founded scientific analyses, and concrete information for the actors in nature conservation are needed. The field of biodiversity genomics can make an important co ... more

Genome sequencing in record time: now it only takes days instead of years

Software assembles complete genome sequences on-demand

23-Feb-2023 National Institutes of Health researchers have developed and released an innovative software tool to assemble truly complete (i.e., gapless) genome sequences from a variety of species. This software, called Verkko, which means “network” in Finnish, makes the process of assembling complete g ... more

Reading out RNA structures in real time

16-Feb-2023 Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease and Stephen Hawking’s disease, is a neurodegenerative disease that results in the gradual loss of control over the muscles in the body. It is currently incurable and the cause of the disease is unknown in over 90% o ... more

Novel way to identify still unknown pathogens

Evolutionary trade-offs: Balancing genetic disease risks and pathogen protection

02-Feb-2023 Certain genes can exist in different, functionally divergent variants in the individuals of a species. If they lead to clear differences, for example in a phenotype or susceptibility to disease, this is known in biology as a polymorphism. Typical examples are a number of genes whose variant ... more

The architecture of shattered genomes

Hunting for disease clues in the dark matter of our DNA

20-Jan-2023 Scientists have reconstructed the chromosomes of patients with an extremely high number of aberrations in their genome that could alter the expression of nearby genes and potentially cause disease. Their results were published in Nature Communications in October 2022.  “We are only beginnin ... more

How a CRISPR protein might yield new tests for many viruses

18-Jan-2023 In a first for the genetic toolset known as CRISPR, a recently discovered protein has been found to act as a kind of multipurpose self-destruct system for bacteria, capable of degrading single-stranded RNA, single-stranded DNA and double-stranded DNA. With its abilities to target so many ty ... more

Molecular archeology: 1200-year-old DNA sequences from Madagascar lead to the discovery of an extinct tortoise

Genetic analyses reveal the lost world of giant tortoises in the western Indian Ocean

13-Jan-2023 An international research team led by Senckenberg scientist Uwe Fritz has succeeded in sequencing the genetic material of up to 1200-year-old tortoise finds from the western Indian Ocean. This led to the discovery of a tortoise species from Madagascar that went extinct in the Middle Ages an ... more

Bruker Announces Acquisition of ACQUIFER Imaging GmbH

Adding Big-Data Management and High-Content Screening Solutions for Bioimaging Applications

06-Jan-2023 Bruker Corporation announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage and networking technology that complements Bruker’s adva ... more

All news on bioanalytics

Successful exit: Miltenyi Biotec acquires biosensor company lino Biotech

21-Mar-2023 lino Biotech, a biosensor company and the world’s only provider of Focal Molography®, announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new ... more

INTEGRA Biosciences acquires start-up Miroculus to accelerate genomics

20-Mar-2023 INTEGRA Biosciences announced that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant tim ... more

BluCon Biotech and LG Chem enter into unique investment agreement

BluCon Biotech's technology has the potential to be a disruptive game changer in the world's plastics market

16-Mar-2023 BluCon Biotech, a German biotech company, and LG Chem, a Korean chemical company, have entered into an investment agreement to scale up and commercialize BluCon Biotech’s proprietary technology to supplement LG Chem´s bio-economy portfolio BluCon Biotech’s technology has the potential to be ... more

Chromologics raises additional funding, bringing the series seed to a total of EUR 12.6 M

15-Mar-2023 Chromologics, the Danish biotech company specializing in production of innovative natural food colors, today announced the successful closure of an extended seed round. The company raised an additional EUR 7.1 million in equity from its existing investors plus two new investors.  "We are th ... more

New method transforms algae shells into technologically relevant functional materials

Scientists Transform Algae into Unique Functional Perovskites with Tunable Properties

14-Mar-2023 Scientists have transformed single-cell algae into functional perovskite materials. The team led by scientists at the B CUBE – Center for Molecular Bioengineering at TU Dresden converted mineral shells of algae into lead halide perovskites with tunable physical properties. The new perovskit ... more

How a metabolite causes inflammation and disease

The accumulation of the metabolite fumarate in the mitochondrion, the powerhouse of a cell, can cause inflammation associated with diseases such as cancer and autoimmune diseases

13-Mar-2023 A new study shows for the first time a connection between a mitochondrial metabolite and the activation of an inflammatory response. Mitochondria are functional units of our cells that fulfil important tasks, i.e. chemical reactions, for the functioning of the cell. One of these tasks is th ... more

Well-known cancer driver with new functions

13-Mar-2023 In connection with the spread of tumors, the transcription factor SNAIL is an old acquaintance. Scientists from the German Consortium for Translational Cancer Research (DKTK) and the Technical University of Munich (TUM) are now publishing a previously undescribed function of the factor: In ... more

New insights into the bacterial immune system

Proteins for DNA organisation can also defend against plasmids

10-Mar-2023 Research team from Kiel University describes unknown defence mechanism in bacteria that selectively wards off foreign and potentially harmful genetic information. Since the coronavirus pandemic, the particularly rapid evolutionary adaptability of microorganisms such as bacteria or viruses ... more

Artificial intelligence could improve therapy for lymphoma

09-Mar-2023 Hodgkin’s lymphoma, a type of lymph node cancer, requires chemotherapy and radiation therapy that can be very stressful for patients. A research group in Vienna is working on a method to predict the course of the disease with the help of artificial intelligence algorithms. This would facili ... more

Enhancing at-home COVID tests with glow-in-the dark materials

09-Mar-2023 Researchers at the University of Houston are using glow-in-the-dark materials to enhance and improve rapid COVID-19 home tests. If you’ve taken an at-home COVID-19 or pregnancy test, then you’ve taken what is scientifically called a lateral flow assay (LFA) test, a diagnostic tool widely us ... more

All news on biotechnology

‘Glow-in-the-dark’ proteins could help diagnose viral diseases

Diagnose diseases more quickly and easily

17-Mar-2023 Despite recent advancements, many highly sensitive diagnostic tests for viral diseases still require complicated techniques to prepare a sample or interpret a result, making them impractical for point-of-care settings or areas with few resources. But now, a team reporting in ACS Central Sci ... more

Speeding up diagnostics! Entangled photon pairs to help fighting cancer

Significantly reduced measurement times and enhanced reliability in cancer diagnostics

28-Feb-2023 The recently launched QEED project aims to significantly reduce measurement time in clinical cancer diagnostics by developing a spectrally resolved imaging technique based on entangled photon pairs. FBH scientists will develop the required diode lasers and quantum light modules. The in-hous ... more

Fingerprint breakthrough in breast cancer detection

Scientists has successfully developed a pioneering non-invasive method for detecting breast cancer from fingerprints, with 98% accuracy

24-Feb-2023 The researchers found that technology called Matrix Assisted Laser Desorption Ionisation Mass Spectrometry (MALDI MS) can be applied to enhanced fingerprints for the detection of breast cancer. The technology is normally used to map drugs, pharmaceuticals and biological molecules within tis ... more

Indicator of early form of Parkinson’s in stool sample

20-Feb-2023 The so-called isolated REM-sleep behavior disorder is a condition that can provide an indication of Parkinson’s disease well in advance. A research team headed by Professor Dr Erdem Gültekin Tamgüney from Heinrich Heine University Düsseldorf (HHU) has shown that a greater concentration of α ... more

AI with infrared imaging enables precise colon cancer diagnostics

Artificial intelligence and infrared imaging automatically classify tumours and are faster than previous methods

16-Feb-2023 The immense progress in the field of therapy options over the past years has significantly improved the chances of cure for patients with colon cancer. However, these new approaches, such as immunotherapies, require precise diagnosis so that they can be specifically tailored to the individu ... more

Tailor-made Metal Complexes for Medical Diagnostics and Therapy

Chemists study manganese, lutetium, and actinium compounds for potential applications in medicine

08-Feb-2023 Tailor-made chemical complexes of certain elements from the group of metals could be suitable for use in a special way in medical imaging as well as potential applications in personalised precision medicine. This has been demonstrated by a research team led by Prof. Dr Peter Comba at the In ... more

Catching the wrongdoers in the act

Chemists develop a novel tool to decipher bacterial infections in real time

07-Feb-2023 A research team led by Professor Xiang David LI from the Department of Chemistry at The University of Hong Kong (HKU) has developed a novel chemical tool to reveal how bacteria adapt to the host environment and control host cells. This tool can be used to investigate bacterial interactions ... more

Voice data as a biomarker for disease

audEERING launches online platform for AI-based analysis of disease symptoms based on voice

31-Jan-2023 The voice AI company audEERING has developed AI SoundLab, a DSGVO-compliant online platform that for the first time enables the determination of health conditions based on parameters of the human voice. Companies and institutions are thus able to explore voice data as biomarkers for disease ... more

Hope for patients with a severe rare disease

By combining the results of multiple molecular analyses, scientists can better diagnose the hereditary disease methylmalonaciduria

30-Jan-2023 New research offers potential benefits for those affected by the hereditary metabolic disease methylmalonic aciduria. By combining the results of multiple molecular analyses, scientists can better diagnose this rare and severe disease. In the future, an improved understanding of the disease ... more

Diagnosing cancer in minutes

Identify tumour margins directly in the surgery room: Refined Laser Systems raises €2.7m

30-Jan-2023 Refined Laser Systems, a dynamic biophotonics company specialised in pioneering laser systems for SRS-microscopy and quantum technology, today announces a Seed funding round of €2.7 million led by High-Tech Gründerfonds and APEX Ventures, along with NRW.BANK, Onsight Ventures and Papst Vent ... more

All news on diagnostics

INTEGRA Biosciences acquires start-up Miroculus to accelerate genomics

20-Mar-2023 INTEGRA Biosciences announced that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant tim ... more

GSG GENII Software Group acquires iVention

17-Mar-2023 GSG GENII Software Group announces that it has completed the acquisition of iVention. iVention provides laboratories in a wide range of industries with its powerful and flexible iVention Lab Execution System (iLES), a software system designed specifically for and around the laboratory proce ... more

Waldner strengthens its presence and service offerings in Australia

03-Mar-2023 The Waldner group - operating in Australia as Waldner Pty Ltd - is now strengthening its presence and service offerings in Australia by acquiring Laboratory Systems Group Pty Ltd (Lilydale/Melbourne), a pioneer in Australia for lab solutions designed for maximum safety and optimum performan ... more

Eppendorf: New production site in Shanghai metropolitan region

Centrifuge business to be bolstered in the growth market of China

14-Feb-2023 The globally positioned Eppendorf Group is expanding its production operation in the Chinese market. The company signed a contract for a new production site in Shanghai metropolitan region on February 8. Eppendorf centrifuges will be made here for the local market. “This is an important and ... more

Ziath acquired by Azenta

09-Feb-2023 Sample management specialists - Ziath announced their acquisition by Azenta Inc (Burlington, MA, USA). Founded in 2005, the Ziath range of innovative 2D barcode readers are a key component of the laboratory automation workflow serving pharmaceutical, biotech and academic customers worldwide ... more

Thermo Fisher Scientific announces collaboration with Celltrio

Unlock fully automated cell line production

08-Feb-2023 Thermo Fisher Scientific and Celltrio, a manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum w ... more

Voice-activated system for hands-free, safer DNA handling

Technology protects researchers from dangerous samples

03-Feb-2023 Smart voice assistants are a popular way for people to get quick answers or play their favorite music. That same technology could make the laboratory safer for scientists and technicians who handle potentially infectious samples. Researchers in ACS Sensors now report a small, voice-activate ... more

Sartorius with clear double-digit growth in fiscal 2022

Uncertainties due to the global political and economic situation remain high

27-Jan-2023 Following extraordinary growth in 2020 and 2021, the life science group Sartorius again outperformed the market in fiscal 2022, achieving its targets for sales revenue and profitability. Both divisions contributed to this development and, according to preliminary figures, recorded double-di ... more

DSM and LabTwin enter into cooperation

DSM chooses LabTwin to advance their digitalization strategy in Science & Innovation with the latest voice and AI solutions

20-Dec-2022 Royal DSM N.V. and LabTwin GmbH announce a multi-year license and collaboration agreement. DSM will apply the newly acquired technology in several of their Science & Innovation laboratories globally. Together, we intend to transform how science is performed in research and application labs ... more

Sartorius with continued growth in a challenging environment

Uncertainties due to the global political and economic situation currently remain high

19-Oct-2022 Sartorius closed the first nine months of 2022 in both divisions with double-digit sales revenue and earnings growth and specified its outlook for the current fiscal year. “In the first nine months, Sartorius achieved significant growth in a challenging environment. Both divisions recorded ... more

All news on laboratory equipment / supplies

Known active ingredient as new drug candidate against “monkeypox”

21-Mar-2023 Mpox – previously known as "monkeypox" – is currently spreading worldwide. An international research team from Goethe University and the University of Kent has now identified a compound that could help fight the disease. Their study has been published in the “Journal of Medical Virology”. N ... more

Successful exit: Miltenyi Biotec acquires biosensor company lino Biotech

21-Mar-2023 lino Biotech, a biosensor company and the world’s only provider of Focal Molography®, announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new ... more

Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform

A revolution in drug discovery thanks to a new chat assistant?

16-Mar-2023 Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform. The new feature, “ChatPandaGPT,” enables researchers to h ... more

Yokogawa Acquires Fluence Analytics, a Pioneer in Digitalizing the Monitoring of Polymerization Reaction Processes

Enabling continuous real-time monitoring of polymers and biopolymers: Gamechanger for the polymer and biopharmaceutical industry

14-Mar-2023 Yokogawa Electric Corporation announces the acquisition of Fluence Analytics, Inc., a US-based startup that provides real-time analytics solutions to polymer and biopharmaceutical companies worldwide. Since signing investment and collaboration agreements in August 2021, the two companies ha ... more

Artificial intelligence could improve therapy for lymphoma

09-Mar-2023 Hodgkin’s lymphoma, a type of lymph node cancer, requires chemotherapy and radiation therapy that can be very stressful for patients. A research group in Vienna is working on a method to predict the course of the disease with the help of artificial intelligence algorithms. This would facili ... more

New organ-on-chip pilot seeks to reduce animal testing in consumer health industry

Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital

08-Mar-2023 A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software. The pilot project, supported by esqLABS, Dynamic42, Placenta Lab of Jena Un ... more

"Dr Jekyll and Mr Hyde" technique to fight cancer

Viennese start-up develops novel, precise anti-cancer drugs

06-Mar-2023 RIANA Therapeutics, a promising pharmaceutical start-up recently spun out of the University of Veterinary Medicine Vienna (Vetmeduni), aims to develop novel therapeutics for cancer patients based in part on scientific findings from Vetmeduni’s Moriggl research group (Moriggl Lab). The techn ... more

Fiscal 2022: Merck Delivers Profitable Growth Despite Challenges

Forecast for 2023: further growth in net sales expected despite increasing headwinds

02-Mar-2023 Merck delivered profitable growth despite challenges in fiscal 2022. Group net sales increased by 12.9% (organically: 6.4%) to € 22,232 million compared with the previous year. Sales growth was driven by all regions and business sectors, particularly Life Science. The Big 3 businesses – Pro ... more

Almost 500 million for investments in start-ups

Final closing exceeds expectations for HTGF

01-Mar-2023 High-Tech Gründerfonds (HTGF) has attracted a total volume of 493.8 million euros for its fourth fund generation at final closing. This makes HTGF IV its biggest ever fund. The seed investor, which invests in technology start-ups in the fields of digital tech, industrial tech, life sciences ... more

Bayer: Significant growth in sales and earnings

Exceptionally strong performance at Crop Science

28-Feb-2023 The Bayer Group achieved strong growth last year, posting significantly higher sales and earnings. “2022 was a very successful year for Bayer despite the challenging environment. We were able to deliver, even during these difficult times, and met the upgraded financial targets we set in Aug ... more

All news on pharma

Known active ingredient as new drug candidate against “monkeypox”

21-Mar-2023 Mpox – previously known as "monkeypox" – is currently spreading worldwide. An international research team from Goethe University and the University of Kent has now identified a compound that could help fight the disease. Their study has been published in the “Journal of Medical Virology”. N ... more

Where the HI-Virus sleeps in the brain

20-Mar-2023 The human immunodeficiency virus HIV-1 is able to infect various tissues in humans. Once inside the cells, the virus integrates its genome into the cellular genome and establishes persistent infections. The role of the structure and organisation of the host genome in HIV-1 infection is not ... more

Immune-cell booster for cancer patients

“This would make it possible to administer cells from any donor to any patient” - Spin-off company planned

20-Mar-2023 Cancer patients might one day benefit from being administered immune cells from healthy donors. But as things stand, receiving donor cells can cause severe or even fatal immune reactions. A researcher at ETH Zurich has now developed a technology that avoids these. Edo Kapetanovic is a medic ... more

New targeting opportunities discovered against canine distemper virus

Structure of the canine distemper virus "docking protein" determined and depicted it at molecular level for the first time - and this can also help with measles

16-Mar-2023 The highly contagious canine distemper virus is dangerous to dogs and wild life animals. It is also closely related to the equally highly contagious measles virus. Researchers at the University of Bern and the Zurich University of Applied Sciences have now for the first time determined the ... more

PFAS can suppress white blood cell’s ability to destroy invaders

16-Mar-2023 In a new study, researchers found that the PFAS chemical GenX suppresses the neutrophil respiratory burst – the method white blood cells known as neutrophils use to kill invading pathogens. The study is an important first step in understanding how both legacy and emerging PFAS chemicals mig ... more

Massive efforts needed to reduce salt intake and protect lives

15-Mar-2023 A first-of-its-kind World Health Organization (WHO) Global report on sodium intake reduction shows that the world is off-track to achieve its global target of reducing sodium intake by 30% by 2025.  Sodium, an essential nutrient, increases the risk of heart disease, stroke and premature dea ... more

Precise attack on tumor remnants

Targeting brain tumors: new drug candidate in clinical trial

15-Mar-2023 Clinical trials are a milestone in the development of safe and effective drugs and therapies. An antibody developed by Helmholtz Munich is now entering a phase 1 clinical trial. Together with the radiopharmaceutical company ITM Isotope Technologies Munich and Münster University Hospital, re ... more

Triggering bitter taste receptors could someday treat asthma, COPD

Surprisingly, bitter taste receptors are not only located in the mouth, but also elsewhere in the body, including the airways

15-Mar-2023 Activating those receptors opens up lung passageways, so they’re a potential target for treating asthma or chronic obstructive pulmonary disease (COPD). Now, researchers report in ACS’ Journal of Medicinal Chemistry that they have designed a potent and selective compound that could lead the ... more

Immune cells have a backup mechanism

If the TBK1 enzyme is mutated, susceptibility to viral infections increases – unless it is missing

14-Mar-2023 The enzyme TBK1 is an important component of the innate immune system that plays a critical role in the defense against viruses. Upon mutation-induced loss of TBK1 function, patients show an increased susceptibility to viral infections. Strikingly, if TBK1 is not expressed at all, this clin ... more

Fungal spores hijack lung cells

New target against Aspergillus fumigatus discovered

14-Mar-2023 The pathogenic fungus Aspergillus fumigatus escapes elimination from surface cells of the human lung by binding to a human protein. In doing so, it is able to nest in so called phagosomes, confined areas in the lung cells, and thus prevents cell processes that would kill the fungus from bei ... more

All news on healthcare
News by department
  • Products

    Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform

    A revolution in drug discovery thanks to a new chat assistant?

    16-Mar-2023 Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform. The new feature, “ChatPandaGPT,” enables researchers to h ... more

    Chromologics raises additional funding, bringing the series seed to a total of EUR 12.6 M

    15-Mar-2023 Chromologics, the Danish biotech company specializing in production of innovative natural food colors, today announced the successful closure of an extended seed round. The company raised an additional EUR 7.1 million in equity from its existing investors plus two new investors.  "We are th ... more

    "Dr Jekyll and Mr Hyde" technique to fight cancer

    Viennese start-up develops novel, precise anti-cancer drugs

    06-Mar-2023 RIANA Therapeutics, a promising pharmaceutical start-up recently spun out of the University of Veterinary Medicine Vienna (Vetmeduni), aims to develop novel therapeutics for cancer patients based in part on scientific findings from Vetmeduni’s Moriggl research group (Moriggl Lab). The techn ... more

  • Business

    Successful exit: Miltenyi Biotec acquires biosensor company lino Biotech

    21-Mar-2023 lino Biotech, a biosensor company and the world’s only provider of Focal Molography®, announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new ... more

    INTEGRA Biosciences acquires start-up Miroculus to accelerate genomics

    20-Mar-2023 INTEGRA Biosciences announced that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant tim ... more

    GSG GENII Software Group acquires iVention

    17-Mar-2023 GSG GENII Software Group announces that it has completed the acquisition of iVention. iVention provides laboratories in a wide range of industries with its powerful and flexible iVention Lab Execution System (iLES), a software system designed specifically for and around the laboratory proce ... more

  • Price Development

    Are the high prices of cancer drugs justified?

    Does the cost correspond to the particular drug’s effectiveness in combating the disease?

    05-May-2020 Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit. The researchers are therefore calling for the clin ... more

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

  • Research

    Known active ingredient as new drug candidate against “monkeypox”

    21-Mar-2023 Mpox – previously known as "monkeypox" – is currently spreading worldwide. An international research team from Goethe University and the University of Kent has now identified a compound that could help fight the disease. Their study has been published in the “Journal of Medical Virology”. N ... more

    Where the HI-Virus sleeps in the brain

    20-Mar-2023 The human immunodeficiency virus HIV-1 is able to infect various tissues in humans. Once inside the cells, the virus integrates its genome into the cellular genome and establishes persistent infections. The role of the structure and organisation of the host genome in HIV-1 infection is not ... more

    Survival specialists on Mount Everest

    Humans are leaving behind a ‘frozen signature’ of hardy microbes

    20-Mar-2023 Almost 5 miles above sea level in the Himalayan mountains, the rocky dip between Mount Everest and its sister peak, Lhotse, lies windswept, free of snow. It is here at the South Col where hundreds of adventurers pitch their final camp each year before attempting to scale the world’s tallest ... more

  • People

    Bill Anderson to become CEO of Bayer AG

    09-Feb-2023 The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Anderson was elected unanimously after a thorough selection process which began mid last year. Werne ... more

    Change at the top of Analytik Jena

    Ulrich Krauss charts new course

    01-Feb-2023 A change is taking place at the top at Analytik Jena. Managing Director Ulrich Krauss has decided to assume other responsibilities outside of Analytik Jena. The Endress+Hauser Group is therefore handing over the management of the subsidiary specializing in laboratory analysis to Oliver Klae ... more

    Carbios strengthens its management team

    Reduce plastic pollution through biorecycling

    27-Jan-2023 Carbios, a pioneer in the development of enzymatic solutions for the recycling of plastic and textile polymers, has strengthened its leadership team with the appointment of Martine BRISSET as Senior Vice President, effective January 1, 2023. Martine BRISSET will lead the Biodegradation Busi ... more

  • Finances

    BluCon Biotech and LG Chem enter into unique investment agreement

    BluCon Biotech's technology has the potential to be a disruptive game changer in the world's plastics market

    16-Mar-2023 BluCon Biotech, a German biotech company, and LG Chem, a Korean chemical company, have entered into an investment agreement to scale up and commercialize BluCon Biotech’s proprietary technology to supplement LG Chem´s bio-economy portfolio BluCon Biotech’s technology has the potential to be ... more

    Chromologics raises additional funding, bringing the series seed to a total of EUR 12.6 M

    15-Mar-2023 Chromologics, the Danish biotech company specializing in production of innovative natural food colors, today announced the successful closure of an extended seed round. The company raised an additional EUR 7.1 million in equity from its existing investors plus two new investors.  "We are th ... more

    Fiscal 2022: Merck Delivers Profitable Growth Despite Challenges

    Forecast for 2023: further growth in net sales expected despite increasing headwinds

    02-Mar-2023 Merck delivered profitable growth despite challenges in fiscal 2022. Group net sales increased by 12.9% (organically: 6.4%) to € 22,232 million compared with the previous year. Sales growth was driven by all regions and business sectors, particularly Life Science. The Big 3 businesses – Pro ... more

  • Cooperation

    New organ-on-chip pilot seeks to reduce animal testing in consumer health industry

    Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital

    08-Mar-2023 A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software. The pilot project, supported by esqLABS, Dynamic42, Placenta Lab of Jena Un ... more

    BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment

    Development of a CRISPR-derived technology platform for cancer treatment

    06-Mar-2023 BRAIN Biotech AG announced the signing of a joint development agreement (JDA) with TransCode Therapeutics, Inc. The objective of the JDA is to co-develop a platform technology that combines a Class 2 CRISPR nuclease, the cell-killing G-dase E, developed by BRAIN Biotech's Akribion Genomics ... more

    Thermo Fisher Scientific announces collaboration with Celltrio

    Unlock fully automated cell line production

    08-Feb-2023 Thermo Fisher Scientific and Celltrio, a manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum w ... more

  • Technology

    Effective metal extraction with electron-stimulated microorganisms by bioleaching

    14-Jul-2022 As part of the project "BioIntElekt" (Development of an innovative small-scale, low-energy electron beam source integrated in a bioreactor system, funding reference: 601015) funded by the Fraunhofer-Gesellschaft in an internal program, metals should be mobilized with the help of bacteria. A ... more

    The 7th BioProScale Symposium took place again as in-person event in Berlin

    New ways of thinking are required: Scientists from both academia and industry presented and discussed innovative approaches and developments in biotechnology and bioprocess engineering

    12-Apr-2022 On the subject of “Scaling Up and Down of Bioprocesses: Technological Innovation and Cell Physiology Insights”, the 7th Symposium was again held on-site in Berlin from March 28 to 31, 2022. In parallel, there was also the possibility to follow the presentations online. The symposium was org ... more

    World's first toxicology testing strategy without animal testing adopted by OECD

    Success for long-standing collaboration between BASF and Givaudan to develop and validate alternative methods

    30-Jun-2021 The world’s first toxicology testing strategy without animal testing has been approved by the OECD (Organisation for Economic Co-operation and Development). The testing strategy consists of three so-called alternative methods. They can be used to predict whether a substance causes allergic ... more

  • Laws

    Japan and Singapore Grant CRISPR Patents to Merck

    27-Nov-2019 Merck announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. “Paired nickases represent a significant step in incre ... more

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

    05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more

  • Market

    MIMETAS Elected Most Innovative Company of the Netherlands

    04-Nov-2022 MIMETAS is the winner of the Dutch Innovation Award 2022. This award recognizes the company's considerable focus on innovation, contribution to the reduction of animal experimentation, leadership, organization, cooperation with partners, and market position. Henk Volberda, chairman of the j ... more

    M&A in chemicals and life sciences slowed down by global lockdowns

    Race for COVID-19 vaccine

    13-Jul-2020 In the first half of this year, the transaction volume of mergers and acquisitions in the chemical and life sciences industries has decreased dramatically. The volume of deals announced in the first six months is only $84 billion. Compared to the previous year (389 billion dollars), this is ... more

    Many of the deadliest cancers receive the least amount of research funding

    'Embarrassing' or stigmatized cancers like lung and liver are underfunded

    23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more

  • Politics

    BioM and Munich Biotech Cluster celebrate its 25th anniversary

    A quarter century of success in biotechnology

    01-Aug-2022 BioM and the Munich Biotech Cluster celebrated their 25th anniversary. Together, they can claim a great success story. With the support of the biotech cluster management organization, the life science region has become one of the most successful biotech hotspots in Europe. At the celebratio ... more

    Chemical pollution threatens biodiversity

    Scientists say more environmental pollutants should be considered in species protection

    20-Jun-2022 Environmental chemical pollution threatens biodiversity. However, the complexity of this pollution remains insufficiently recognised by decision-makers - this is what international researchers led by Gabriel Sigmund from the University of Vienna and Ksenia Groh from the Swiss Federal Instit ... more

    CureVac and GSK Enter into Pandemic Preparedness Contract with German Government

    Five-year contract enables production of up to 80 million vaccine doses at short notice in case of a public health emergency

    12-Apr-2022 CureVac N.V. and GSK announced that they have entered into a contract with the German federal government to supply mRNA vaccines within a broader tender for pandemic preparedness in Germany. Following a setup period of a maximum of two years, the contract grants the German federal governmen ... more

  • Manufacturing

    Lonza Completes Expansion of Conjugation Facility in Visp

    Expansion adds development and manufacturing capacity for pre-clinical, clinical and commercial supply of bioconjugates and antibody-drug conjugates

    20-Feb-2023 Lonza announced that a planned expansion of its bioconjugation facility in Visp (CH) is complete.  The expansion includes two manufacturing suites and supporting infrastructure. It will support an extended customer portfolio, including companies entering clinical development. The investment ... more

    Eppendorf: New production site in Shanghai metropolitan region

    Centrifuge business to be bolstered in the growth market of China

    14-Feb-2023 The globally positioned Eppendorf Group is expanding its production operation in the Chinese market. The company signed a contract for a new production site in Shanghai metropolitan region on February 8. Eppendorf centrifuges will be made here for the local market. “This is an important and ... more

    Michroma Closes $6.4 Million Seed Round to Bring Novel Food Coloring to Market

    Ingredient biotech startup Michroma is on track to expand and scale fungal food colors platform

    07-Feb-2023 Michroma, a leading precision fermentation food ingredient company, today announced it has closed $6.4 million in seed financing. The round will fast-track the company's commercialization of sustainable natural colorants, expand research and development capabilities, and broaden Michroma's ... more

  • Career

    Work ability is influenced by physical fitness, social life and cognitive functions

    01-Feb-2023 Due to demographic change, it is becoming increasingly important to maintain the working capacity of ageing workforces. In a recent study, researchers from the Leibniz Research Centre for Working Environments and Human Factors in Dortmund (IfADo) therefore investigated the relationship betw ... more

    High-Tech Business KNAUER Awarded for its Family Friendliness

    03-Nov-2021 The Berlin-based company makes sure its employees are well looked after, providing support for employees and their families, especially throughout the difficult times of the pandemic. KNAUER was officially recognized as the family friendliest company in Berlin that has more than 100 employe ... more

    Eppendorf with worldwide setting program

    Around 250 vacancies at all locations by the end of 2019

    26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE